Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube

Understanding the Barriers and Facilitators of Implementing a Controlled Substance Safety Committee

BRIEF REPORT

Mechelle Sanders, PhD; Anna Russell, BS; Kaela Mali, BS; Jenny Ganay Vasquez, BS; Sean Chambers, BS; Holly Ann Russell, MD, MS

Corresponding Author: Mechelle Sanders, PhD; University of Rochester, Department of Family Medicine

Email: Mechelle_sanders@urmc.rochester.edu

DOI: 10.3122/jabfm.2024.240220R3

Keywords: Centers for Disease Control and Prevention (U.S.), Controlled Substances, Drug Control, Family Medicine, Implementation Science, Motivation, Opioids, Pain Management, Physician's Practice Patterns, Safety

Dates: Submitted: 06-05-2024; Revised: 08-07-2024; 10-25-2024; 01-14-2025; Accepted: 01-29-2025

Status: In production for ahead of print. 

PURPOSE: The few studies about primary care based controlled substance safety committees (CSSC) to date have been primarily quantitative, focused on patient outcomes and lacked contextual data around their implementation. The purpose of this study is to qualitatively identify barriers and facilitators to the use of CDCs guidelines around opioid prescribing and the implementation of controlled substance safety committee in a primary care practice.

METHODS: Ten semi-structured interviews were conducted with primary care clinicians in an academic medical practice. Potential barriers and facilitators to the uptake and use of the CDC opioid guidelines and the practice’s CSSC were coded and analyzed against the Capability, Opportunity, and Motivation framework for Behavior change framework (COM-B).

RESULTS: Six key themes were identified around uptake of the CDC guidelines. In general, the CSSC addressed some of the capability barriers around the guidelines but had limited impact on increasing motivation to follow the guidelines. We found the same recommendation in the guidelines could have differing impact on prescribing behavior.

CONCLUSIONS: Simply promoting guidelines may be insufficient, especially for those viewing them as rules rather than recommendations. Our findings underscore the fact that guidelines are merely a starting point, not an endpoint of implementation. 

ABSTRACTS IN PRESS

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire